[ad_1] NuCana plunges after trial setback for cancer drug [ad_2] Source: Seekingalpha
Browsing: cancer
[ad_1] HUTCHMED pulls regulatory submission for Takeda-partnered cancer drug in China [ad_2] Source: Seekingalpha
[ad_1] NuCana plunges after trial setback for cancer drug [ad_2] Source: Seekingalpha
[ad_1] HUTCHMED pulls regulatory submission for Takeda-partnered cancer drug in China [ad_2] Source: Seekingalpha
[ad_1] NuCana plunges after trial setback for cancer drug [ad_2] Source: Seekingalpha
[ad_1] Merck stops two more cancer trials over poor results [ad_2] Source: Seekingalpha
[ad_1] Nuvectis gains on FDA’s orphan drug designation for cancer therapy [ad_2] Source: Seekingalpha
[ad_1] Roman Didkivskyi Siemens Healthineers (OTCPK:SEMHF) is wanting to pay greater than €200M ($224M) to purchase a Novartis (NYSE:NVS) business targeted on producing radioactive chemical compounds…
[ad_1] JHVEPhoto BeiGene (NASDAQ:BGNE) has obtained FDA Fast Track Designation for its investigational cancer therapy. BGB-16673, an orally obtainable BTK-targeting chimeric degradation activation compound, gained fast…
[ad_1] Regeneron Pharmaceuticals (NASDAQ:REGN) mentioned on Monday its bispecific antibody Ordspono (odronextamab) has been cleared by the European Commission for the therapy of relapsed/refractory follicular lymphoma…